Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Наслов

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Идентификатор

/unibl/sci/idNaucniRad:36017
/unibl/sci/idNaucniRad:24617

Тип

Датум

Библиографски цитат

LJ. Božić, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, Aug, 2018

Је дио

Листа аутора

Position: 138238 (13 views)